Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
10/2011
10/04/2011US8030311 Phenylacetamides suitable as protein kinase inhibitors
09/2011
09/29/2011WO2011117449A1 Enantiomers of benzoheteroepine derivatives and use thereof as anti-carcinogenic agents
09/29/2011US20110237607 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
09/29/2011US20110237606 3-Deazaneplanocin Derivatives
09/29/2011US20110237532 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
09/29/2011US20110236952 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof
09/28/2011CN102203096A Compounds that expand hematopoietic stem cells
09/28/2011CN102203095A Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
09/28/2011CN102203067A Hedgehog pathway modulators
09/28/2011CN102199223A Extraction method of lentinan, eritadenine and mushroom dietary fiber
09/28/2011CN102199151A 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use
09/28/2011CN101245067B Process for producing entecavir and midbody
09/27/2011US8026245 HIV replication inhibiting purine derivatives
09/27/2011US8026244 Thioxanthine derivatives and their use as inhibitors of MPO
09/22/2011WO2011114336A1 Process for the isolation of ganciclovir intermediate
09/22/2011WO2011113802A2 Imidazopyridine compounds, compositions and methods of use
09/22/2011US20110230659 Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug
09/22/2011US20110230503 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions
09/22/2011US20110230479 Neurotrophin mimetics and uses thereof
09/22/2011US20110230464 Purine derivatives useful as p13 kinase inhibitors
09/22/2011US20110229918 Method of Quantifying Transient Interactions Between Proteins
09/22/2011US20110229500 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
09/22/2011CA2793024A1 Imidazopyridine compounds, compositions and methods of use
09/14/2011EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
09/14/2011EP2364086A1 Novel antithrombotic diadenosine tetraphosphates and related analogs
09/09/2011WO2011109587A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/09/2011WO2011058027A3 N-9-substituted purine compounds, compositions and methods of use
09/09/2011CA2791715A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/08/2011US20110218197 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/07/2011EP2362811A2 Apparatus and method using rotary flow distribution mechanisms
09/07/2011CN102177159A Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
09/07/2011CN102176911A Novel adenine derivatives
09/07/2011CN101233133B Hydrochlorides and hydrates of 1-[(3-cyanopyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)xanthine, their preparation and their use as medicaments
09/06/2011US8012995 Pharmaceutically active sulfonamide derivatives
09/06/2011US8012964 9-substituted 8-oxoadenine compound
09/06/2011CA2488642C Aryl carbonyl derivatives as glucokinase activators
09/01/2011WO2011106168A1 Purine compounds for treating autoimmune and demyelinating diseases
09/01/2011US20110212467 INHIBITORS OF dUTPase
08/2011
08/25/2011WO2011102806A1 Process for preparing entecavir and its intermediates
08/25/2011US20110207931 Preparation of valganciclovir and its salts
08/25/2011CA2782654A1 Process for preparing entecavir and its intermediates
08/24/2011EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/24/2011EP2358710A1 Akt and p70 s6 kinase inhibitors
08/24/2011CN102161661A Chiral acyclic purine nucleoside compound with antiviral activity, and preparation method thereof
08/23/2011US8003656 2-phenoxy pyrimidinone analogues
08/18/2011WO2011100698A2 Methods of treating viral infection
08/18/2011WO2011098452A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/18/2011WO2011098451A1 Purine derivatives and their pharmaceutical uses
08/18/2011WO2011041399A3 Pi3k (delta) selective inhibitors
08/18/2011US20110201810 Method for Preparing 4-[9-(6-Aminopurine)]-2-(S)-Hydroxyl-Butyric Acid Methyl Ester
08/18/2011US20110201809 Process for Preparing Entecavir and its Intermediates
08/18/2011US20110201808 Novel compound having affinity to amyloid
08/18/2011US20110201629 Cyclohexyl amide derivatives as crf receptor antagonists
08/18/2011CA2786973A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/17/2011EP1444233B1 A2b adenosine receptor antagonists
08/17/2011CN102159576A Improved production method for adefovir dipivoxil
08/11/2011WO2011095450A1 Cyclohexyl amide derivatives as crf receptor antagonists
08/11/2011WO2011012269A3 Method and substances for preparation of n-substituted pyridinium compounds
08/10/2011CN102149715A Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof
08/04/2011US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors
08/03/2011EP2351751A1 Substituted pyrazolopyrimidines
08/03/2011EP2350078A2 Compounds that expand hematopoietic stem cells
08/03/2011EP1490368B1 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents
08/03/2011CN102143964A Method for producing adenine compound
08/02/2011US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
07/2011
07/28/2011WO2011089401A1 Crystalline forms of a purine derivative
07/28/2011US20110184003 Compounds and methods for the treatment of viral infection
07/28/2011US20110183992 Therapeutic agent for migraine
07/28/2011US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
07/28/2011US20110182973 Polymerase inhibitors and the use thereof for the treatment of tumors
07/27/2011EP2346508A1 Heterocyclic kinase inhibitors
07/27/2011CN102134241A Synthesis method of xanthinol nicotinate
07/27/2011CN101602765B 6-alkyl amino-2-alkylthio-9-ester-containing alkylpurine derivatives and method for synthesizing same
07/27/2011CN101563346B Process for the preparation of abacavir
07/27/2011CN101282977B Xanthine derivatives as selective hm74a agonists
07/26/2011US7985754 Selective antagonists of A2A adenosine receptors
07/26/2011CA2528931C Inosine derivatives and production methods therefor
07/21/2011US20110178267 Novel organic materials and methods for obtaining thereof
07/21/2011US20110178069 Inhibitors of interleukin-1 beta converting enzyme
07/21/2011US20110178031 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
07/21/2011US20110177007 Dithienopyrrole Dyes for Imaging and Therapy
07/21/2011US20110177006 Dithienofuran Dyes for Imaging and Therapy
07/20/2011EP2344501A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
07/20/2011CN102127081A Preparation method of adenine
07/20/2011CN102127080A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
07/20/2011CN101456859B Method for preparing antiviral drug valaciclovir
07/19/2011US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
07/19/2011US7981901 transdermal formulations comprise a skin penetration enhancer; transdermal formulation, which is topically applied to an area of skin superficial to a carotid artery, a temporal artery, a vertebral artery, or to a tender spot associated with a head
07/14/2011WO2011084642A1 Compound suitable for the treatment of synucleopathies
07/14/2011WO2011028507A3 Compositions, methods, and kits for determining an alkyl transferase
07/14/2011US20110172241 Benzazole analogues and uses thereof
07/14/2011US20110172192 Method and compositions for treating hematological malignancies
07/14/2011US20110171130 A3 adenosine receptor antagonists and partial agonists
07/14/2011CA2784744A1 Compound
07/13/2011EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof
07/12/2011US7977378 Compositions and methods for enhancing weight-loss by cyclical administration of compounds
07/12/2011US7977344 Compounds
07/07/2011US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors
07/07/2011US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof
07/06/2011CN102119167A Nucleoside cyclicphosphates
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 120